Furthermore, survival analysis based on The Cancer Genome Atlas (TCGA) data showed that patients classified as “A2M‐AS1‐low” exhibited significantly shorter overall survival than those categorized as “A2M‐AS1‐high” (Figure 1D). The gene discussed is A2M; the disease is cancer.